Role of TGF-beta-Regulated microRNAs on SMC Differentiation
- Xiaochun Long(PI)
- Albany Medical College,
Grant:
Research project
Project status
Finished
About the Project
<p>Smooth muscle cells (SMC) are important in maintaining normal structure and function of blood vessels. SMC can alter their differentiated state in response to diverse stimuli, a process known as phenotypic modulation. Such phenotypic modulation is a hallmark of atherosclerosis, restenosis and hypertension. Myocardin (MYOCD) is a potent co-activator of serum response factor (SRF) and together this transcriptional switch is sufficient for directing SMC contractile phenotype. microRNAs (miRs) have emerged as important post-transcriptional regulators of SMC gene expression. miR-143/145 has drawn considerable attention as critical regulators of the SMC differentiation phenotype. As with other SMC-specific genes, both miR-143/145 are decreased in the neointima of the vessel wall after injury. Thus, miR-143/145 is part of the molecular signature for SMC differentiation. Although the functionality of miR-143/145 has begun to be elucidated, the molecular regulation and related upstream signaling pathways directing its expression in SMC is poorly understood. TGF-beta is a fundamental stimulator for SMC differentiation. In an effort to define a miR expression profile linked to differentiated SMC, I performed a miR array using TGF-beta1 treated human coronary artery smooth muscle cells (HCASM). miR-143/145 was found to be one of the most dramatically induced miRs and preliminary data show the induction of miR-143/145 is accompanied by up-regulation of MYOCD. Additional novel miRs were also identied. This application seeks to build from these exciting data and test the hypothesis that TGF-beta1 controls a subset of miRs critical for SMC differentiation. The first aim will validate TGF-beta1-induced miR-143/145 and MYOCD expression using human and rodent SMC. The second aim will define the molecular regulation of TGF-beta1-induced miR-143/145 using inhibitors and siRNA to key signaling mediators I have already identified to be important. miR-143/145 promoter studies will also be examined. The third aim will elucidate the role of novel TGF-beta1-regulated miRs in SMC phenotype in vitro and in vivo using gain- and loss-of-function approaches. Together, these studies will advance our understanding of the novel role TGF-beta1 plays in regulating SMC phenotype though microRNAs. (AHA Program: Scientist Development Grant)</p>
Project Information
Project Type
Research project
Project Managed By
Time Period
07/01/2010 – 06/30/2014Status
FinishedFunding Details
Role of TGF-beta-Regulated microRNAs on SMC DifferentiationAward
FunderAmount
American Heart Association
308000 USD